Insider Transactions in Q4 2021 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 18
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.4%
|
$10,000
$1.64 P/Share
|
Oct 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.35%
|
$246,400
$40.76 P/Share
|
Oct 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
Oct 14
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
7,055
-4.24%
|
$275,145
$39.91 P/Share
|
Oct 14
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.85%
|
$6,160
$1.64 P/Share
|
Oct 14
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,221
-0.95%
|
$47,619
$39.97 P/Share
|
Oct 14
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
3,215
-1.22%
|
$125,385
$39.97 P/Share
|
Oct 14
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
1,082
-1.51%
|
$42,198
$39.97 P/Share
|
Oct 14
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,273
-0.61%
|
$49,647
$39.97 P/Share
|
Oct 11
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
245
-0.78%
|
$9,310
$38.22 P/Share
|
Oct 07
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
3,250
-9.88%
|
$130,000
$40.11 P/Share
|
Oct 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.15%
|
$458,440
$40.55 P/Share
|
Oct 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.99%
|
$11,461
$1.64 P/Share
|
Oct 05
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.15%
|
$458,440
$40.63 P/Share
|
Oct 05
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.99%
|
$11,461
$1.64 P/Share
|
Oct 01
2021
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,938
+50.0%
|
-
|